Anika to Showcase Joint Preservation & Restoration Portfolio at the 2019 World Congress of the International Cartilage Regene...
October 04 2019 - 8:30AM
Business Wire
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated
regenerative therapies company leveraging its proprietary
hyaluronic acid ("HA") technology platform, today announced plans
to showcase its osteoarthritis pain management and joint
preservation and restoration therapies at the 15th World Congress
of the International Cartilage Regeneration and Joint Preservation
Society (ICRS). The ICRS World Congress, which is being held
October 5-8, 2019 in Vancouver, Canada, is the world’s largest
gathering of scientists, clinicians and industry participants
focused on clinical cartilage repair and basic cartilage
research.
“Anika is committed to expanding its portfolio of regenerative
therapies to become the global leader in joint preservation and
restoration,” said Joseph Darling, President and CEO, Anika
Therapeutics. “We look forward to engaging with orthopedic
specialists at this year’s ICRS World Congress to better understand
the needs of patients and physicians across the joint preservation
and restoration continuum of care.”
Guided, hands-on demonstrations of HYALOFAST procedures using
the HYALOFAST Arthroscopic Virtual Surgery Simulator will be
available at the Anika booth. Details on Anika’s joint preservation
and restoration presentations at the 2019 ICRS World Congress are
below:
October 6, 2019
Anika-Sponsored Lunch Symposium
11:30 am – 12:15 pm PDT
Hyatt Regency Vancouver, Plaza C&B
Title: Preservation & Regeneration: A
Joint Approach
Moderator: Sanjay Anand, Consultant
Orthopaedic Surgeon - Stepping Hill Hospital, Stockport, Alexandra
BMI Hospital, Cheadle - UK
Speakers:
- Dr. Stephen French, Orthopaedic Surgeon - Calgary, Canada;
Clinical Assistant Professor, University of Calgary; CINGAL:
Preservation of Movement with a Combination Therapy for OA
Pain
- Sanjay Anand, Consultant Orthopaedic Surgeon - Stepping Hill
Hospital, Stockport, Alexandra BMI Hospital, Cheadle – UK;
HYALOFAST: One-Step Cartilage Regeneration from Science to
Practice
- Dr. Konrad Slynarski, Head of Clinic - Slynarski Knee Clinic,
Warsaw, Poland; HYALOFAST: Arthroscopic Implantation in a Limited
Access Location: Surgical Technique
October 7, 2019
Company-Sponsored Physician
Education
10:45 am – 11:15 am PDT
Hyatt Regency Vancouver, Anika Booth
#15
- Prof. Stefan Nehrer, Orthopaedic Surgeon at the Department for
Orthopaedic Surgery at the University Hospital in Krems; Professor
for Tissue Engineering at Centre for Regenerative Medicine and Head
of Department for Biomedicine and Health Sciences at Danube
University Krems – Austria; HYALOFAST in the Ankle
- Prof. Mats Brittberg, Orthopaedic Surgeon at Region Halland
Orthopaedics at the Kungsbacka Hospital in Kungsbacka, Sweden;
Professor of Orthopaedics connected to the Institution of Clinical
Sciences and Orthopaedic Department; Member of the Cartilage
Research Unit at University of Gothenburg – Sweden; HYALOFAST in
the Knee
About ICRS
The ICRS (International Cartilage Regeneration and Joint
Preservation Society) is the main forum for international
collaboration in cartilaginous tissue research that brings together
basic scientists, clinical researchers, physicians and members of
industry, engaged or interested in the field of articular biology,
its genetic basis and regenerative medicine. It provides continuing
education and training to physicians and scientists with an active
interest in the prevention and treatment of joint disease to
improve patient care through regenerative medicine approaches.
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ: ANIK) is a global,
integrated regenerative therapies company based in Bedford,
Massachusetts. Anika is committed to delivering therapies to
improve the lives of patients across a continuum of care from
osteoarthritis pain management to joint preservation and
restoration. The Company has over two decades of global expertise
commercializing more than 20 products based on its proprietary
hyaluronic acid (HA) technology platform. For more
information about Anika, please visit
www.anikatherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191004005009/en/
For Investor Inquiries: Anika Therapeutics, Inc. Sylvia Cheung,
781-457-9000 Chief Financial Officer For Media Inquiries: W2O Group
Sonal Vasudev, 917-523-1418 sonal@w2ogroup.com
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Sep 2023 to Sep 2024